The metabolic syndrome: requiescat in pace.
暂无分享,去创建一个
[1] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.
[2] J. K. Dunn,et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[3] G. Miller,et al. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.
[4] Tracey McLaughlin,et al. Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant , 2003, Annals of Internal Medicine.
[5] D. Seligson,et al. Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.
[6] W C Willett,et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.
[7] M. Goran,et al. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. , 2004, The Journal of clinical endocrinology and metabolism.
[8] S. Blair,et al. Prevalence of the metabolic syndrome across cardiorespiratory fitness levels in women. , 2004, Obesity research.
[9] Steven B Heymsfield,et al. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. , 2004, Diabetes care.
[10] G. Reaven,et al. Insulin resistance as a predictor of age-related diseases. , 2001, The Journal of clinical endocrinology and metabolism.
[11] T. Cheng. Metabolic syndrome in China. , 2004, Circulation.
[12] B. Hoffman,et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] James W. Anderson,et al. Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). , 2003, Diabetes care.
[14] A. King,et al. Depression and the Metabolic Syndrome in Young Adults: Findings From the Third National Health and Nutrition Examination Survey , 2004, Psychosomatic medicine.
[15] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[16] J. Hokanson,et al. Hypertriglyceridemia as a cardiovascular risk factor. , 1998, The American journal of cardiology.
[17] Vesa Manninen,et al. Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment , 1992, Circulation.
[18] E. Barrett-Connor,et al. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. , 2004, Diabetes care.
[19] A. Mokdad,et al. Trends in waist circumference among U.S. adults. , 2003, Obesity research.
[20] E. Tai,et al. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. , 2004, Diabetes care.
[21] G. Reaven. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. , 2004, Endocrinology and metabolism clinics of North America.
[22] P. Wilson,et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.
[23] J. Shaw,et al. Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.
[24] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.
[25] G. Reaven,et al. The metabolic syndrome: one step forward, two steps back , 2004, Diabetes & vascular disease research.
[26] C. Lamendola,et al. Insulin Resistance Syndrome , 2004, The Journal of cardiovascular nursing.
[27] D. Simmons,et al. Prevalence of the metabolic syndrome among adult New Zealanders of Polynesian and European descent. , 2004, Diabetes care.
[28] R. Bawol,et al. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. , 1980, The New England journal of medicine.
[29] T. Wilt,et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.
[30] S. Lillioja,et al. Relationship between degree of obesity and in vivo insulin action in man. , 1985, The American journal of physiology.
[31] A. Biggeri,et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. , 2004, Diabetes care.
[32] Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance. , 2003, The American journal of cardiology.
[33] Tracey McLaughlin,et al. Relationship between obesity, insulin resistance, and coronary heart disease risk. , 2002, Journal of the American College of Cardiology.
[34] T. Wilt,et al. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol , 2000 .
[35] S. Haffner,et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.
[36] J. Buring,et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. , 1997, Circulation.
[37] E. Feskens,et al. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.
[38] D. Gordon,et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.
[39] G. Reaven,et al. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. , 1998, The Journal of clinical endocrinology and metabolism.
[40] H. K. Lee,et al. Prevalence of the metabolic syndrome among South Korean adults: the Ansan study , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[41] F. Pi‐Sunyer,et al. Medical Hazards of Obesity , 1993, Annals of Internal Medicine.
[42] G. Reaven,et al. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. , 1974, The Journal of clinical investigation.
[43] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[44] W. Sheu,et al. Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. , 1992, American journal of hypertension.
[45] Jaakko Tuomilehto,et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.
[46] G. Reaven,et al. Impact of degree of obesity on surrogate estimates of insulin resistance. , 2004, Diabetes care.
[47] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[48] T. Valle,et al. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. , 2004, Diabetes care.
[49] M. Davies,et al. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. , 2001, Human reproduction.
[50] C. Lamendola,et al. Differentiation Between Obesity and Insulin Resistance in the Association With C-Reactive Protein , 2002, Circulation.
[51] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[52] M. Akbaba,et al. Prevalence of the metabolic syndrome in a Turkish adult population. , 2004, Diabetes, nutrition & metabolism.
[53] G. Reaven,et al. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. , 2000, Diabetes care.
[54] H. Hein,et al. Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease. , 2001, Archives of internal medicine.
[55] P. Suadicani,et al. High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease. , 2000, Hypertension.
[56] R. Krauss,et al. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. , 1993, The Journal of clinical investigation.
[57] G. Reaven,et al. Prevalence of hyperinsulinaemia in patients with high blood pressure , 1992, Journal of internal medicine.
[58] W. Kannel. Blood pressure as a cardiovascular risk factor: prevention and treatment. , 1996, JAMA.
[59] G. Reaven,et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[60] J. Park,et al. Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[61] Steven B Heymsfield,et al. Comparisons of waist circumferences measured at 4 sites. , 2003, The American journal of clinical nutrition.
[62] D. Gordon,et al. High-Density Lipoprotein Cholesterol and Cardiovascular Disease , 2005 .
[63] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[64] S. Colagiuri,et al. Comment , 2005, Diabetologia.
[65] M. Cavaghan,et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. , 1999, Diabetes care.
[66] C. Aguilar-Salinas,et al. High prevalence of metabolic syndrome in Mexico. , 2004, Archives of medical research.